A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion

Santhi D. Konduri, Chilukuri N. Rao, Nirmala Chandrasekar, Anastasia Tasiou, Sanjeeva Mohanam, Yoshiaki Kin, Sajani S. Lakka, Dzung Dinh, William C. Olivero, Meena Gujrati, Donald C. Foster, Walter Kisiel, Jasti S. Rao

Research output: Contribution to journalArticle

Abstract

Human tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine protease inhibitor that inhibits plasmin, trypsin, chymotrypsin, cathepsin G, and plasma kallikrein but not urokinase-type plasminogen activator, tissue plasminogen activator, or thrombin. Preliminary findings in our laboratory suggested that the expression of TFPI-2 is downregulated or lost during tumor progression in human gliomas. To investigate the role of TFPI-2 in the invasiveness of brain tumors, we stably transfected the human high-grade glioma cell line SNB19 and the human low-grade glioma cell line Hs683 with a vector capable of expressing a transcript complementary to the full-length TFPI-2 mRNA in either sense (0.7 kb) or antisense (1 kb) orientations. Parental cells and stably transfected cell lines were analysed for TFPI-2 protein by Western blotting and for TFPI-2 mRNA by Northern blotting. The levels of TFPI-2 protein and mRNA were higher in the sense clones (SNB19) and decreased in the antisense (Hs683) clones than in the corresponding parental and vector controls. In spheroid and matrigel invasion assays, the SNB19 parental cells were highly invasive, but the sense-transfected SNB-19 clones were much less invasive; the antisense-transfected Hs683 clones were more invasive than their parental and vector controls. After intracerebral injection in mice, the sense-transfected SNB19 clones were less able to form tumors than were their parental and vector controls, and the antisense-Hs683 clones hut not the parental or vector controls formed small tumors. This is the first study to demonstrate that down- or upregulation of TFPI-2 plays a significant role in the invasive behavior of human gliomas.

Original languageEnglish (US)
Pages (from-to)6938-6945
Number of pages8
JournalOncogene
Volume20
Issue number47
DOIs
StatePublished - Oct 18 2001

Fingerprint

Glioma
Clone Cells
Cell Line
Messenger RNA
Down-Regulation
Plasma Kallikrein
Cathepsin G
Neoplasms
Serine Proteinase Inhibitors
tissue-factor-pathway inhibitor 2
Fibrinolysin
Urokinase-Type Plasminogen Activator
Tissue Plasminogen Activator
Brain Neoplasms
Thrombin
Northern Blotting
Proteins
Up-Regulation
Western Blotting
Injections

Keywords

  • Glioblastoma
  • Invasion
  • TFPI-2

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Konduri, S. D., Rao, C. N., Chandrasekar, N., Tasiou, A., Mohanam, S., Kin, Y., ... Rao, J. S. (2001). A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene, 20(47), 6938-6945. https://doi.org/10.1038/sj.onc.1204847

A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. / Konduri, Santhi D.; Rao, Chilukuri N.; Chandrasekar, Nirmala; Tasiou, Anastasia; Mohanam, Sanjeeva; Kin, Yoshiaki; Lakka, Sajani S.; Dinh, Dzung; Olivero, William C.; Gujrati, Meena; Foster, Donald C.; Kisiel, Walter; Rao, Jasti S.

In: Oncogene, Vol. 20, No. 47, 18.10.2001, p. 6938-6945.

Research output: Contribution to journalArticle

Konduri, SD, Rao, CN, Chandrasekar, N, Tasiou, A, Mohanam, S, Kin, Y, Lakka, SS, Dinh, D, Olivero, WC, Gujrati, M, Foster, DC, Kisiel, W & Rao, JS 2001, 'A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion', Oncogene, vol. 20, no. 47, pp. 6938-6945. https://doi.org/10.1038/sj.onc.1204847
Konduri SD, Rao CN, Chandrasekar N, Tasiou A, Mohanam S, Kin Y et al. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene. 2001 Oct 18;20(47):6938-6945. https://doi.org/10.1038/sj.onc.1204847
Konduri, Santhi D. ; Rao, Chilukuri N. ; Chandrasekar, Nirmala ; Tasiou, Anastasia ; Mohanam, Sanjeeva ; Kin, Yoshiaki ; Lakka, Sajani S. ; Dinh, Dzung ; Olivero, William C. ; Gujrati, Meena ; Foster, Donald C. ; Kisiel, Walter ; Rao, Jasti S. / A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. In: Oncogene. 2001 ; Vol. 20, No. 47. pp. 6938-6945.
@article{f298c1114738407a82db92ec2a01a39a,
title = "A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion",
abstract = "Human tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine protease inhibitor that inhibits plasmin, trypsin, chymotrypsin, cathepsin G, and plasma kallikrein but not urokinase-type plasminogen activator, tissue plasminogen activator, or thrombin. Preliminary findings in our laboratory suggested that the expression of TFPI-2 is downregulated or lost during tumor progression in human gliomas. To investigate the role of TFPI-2 in the invasiveness of brain tumors, we stably transfected the human high-grade glioma cell line SNB19 and the human low-grade glioma cell line Hs683 with a vector capable of expressing a transcript complementary to the full-length TFPI-2 mRNA in either sense (0.7 kb) or antisense (1 kb) orientations. Parental cells and stably transfected cell lines were analysed for TFPI-2 protein by Western blotting and for TFPI-2 mRNA by Northern blotting. The levels of TFPI-2 protein and mRNA were higher in the sense clones (SNB19) and decreased in the antisense (Hs683) clones than in the corresponding parental and vector controls. In spheroid and matrigel invasion assays, the SNB19 parental cells were highly invasive, but the sense-transfected SNB-19 clones were much less invasive; the antisense-transfected Hs683 clones were more invasive than their parental and vector controls. After intracerebral injection in mice, the sense-transfected SNB19 clones were less able to form tumors than were their parental and vector controls, and the antisense-Hs683 clones hut not the parental or vector controls formed small tumors. This is the first study to demonstrate that down- or upregulation of TFPI-2 plays a significant role in the invasive behavior of human gliomas.",
keywords = "Glioblastoma, Invasion, TFPI-2",
author = "Konduri, {Santhi D.} and Rao, {Chilukuri N.} and Nirmala Chandrasekar and Anastasia Tasiou and Sanjeeva Mohanam and Yoshiaki Kin and Lakka, {Sajani S.} and Dzung Dinh and Olivero, {William C.} and Meena Gujrati and Foster, {Donald C.} and Walter Kisiel and Rao, {Jasti S.}",
year = "2001",
month = "10",
day = "18",
doi = "10.1038/sj.onc.1204847",
language = "English (US)",
volume = "20",
pages = "6938--6945",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "47",

}

TY - JOUR

T1 - A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion

AU - Konduri, Santhi D.

AU - Rao, Chilukuri N.

AU - Chandrasekar, Nirmala

AU - Tasiou, Anastasia

AU - Mohanam, Sanjeeva

AU - Kin, Yoshiaki

AU - Lakka, Sajani S.

AU - Dinh, Dzung

AU - Olivero, William C.

AU - Gujrati, Meena

AU - Foster, Donald C.

AU - Kisiel, Walter

AU - Rao, Jasti S.

PY - 2001/10/18

Y1 - 2001/10/18

N2 - Human tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine protease inhibitor that inhibits plasmin, trypsin, chymotrypsin, cathepsin G, and plasma kallikrein but not urokinase-type plasminogen activator, tissue plasminogen activator, or thrombin. Preliminary findings in our laboratory suggested that the expression of TFPI-2 is downregulated or lost during tumor progression in human gliomas. To investigate the role of TFPI-2 in the invasiveness of brain tumors, we stably transfected the human high-grade glioma cell line SNB19 and the human low-grade glioma cell line Hs683 with a vector capable of expressing a transcript complementary to the full-length TFPI-2 mRNA in either sense (0.7 kb) or antisense (1 kb) orientations. Parental cells and stably transfected cell lines were analysed for TFPI-2 protein by Western blotting and for TFPI-2 mRNA by Northern blotting. The levels of TFPI-2 protein and mRNA were higher in the sense clones (SNB19) and decreased in the antisense (Hs683) clones than in the corresponding parental and vector controls. In spheroid and matrigel invasion assays, the SNB19 parental cells were highly invasive, but the sense-transfected SNB-19 clones were much less invasive; the antisense-transfected Hs683 clones were more invasive than their parental and vector controls. After intracerebral injection in mice, the sense-transfected SNB19 clones were less able to form tumors than were their parental and vector controls, and the antisense-Hs683 clones hut not the parental or vector controls formed small tumors. This is the first study to demonstrate that down- or upregulation of TFPI-2 plays a significant role in the invasive behavior of human gliomas.

AB - Human tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine protease inhibitor that inhibits plasmin, trypsin, chymotrypsin, cathepsin G, and plasma kallikrein but not urokinase-type plasminogen activator, tissue plasminogen activator, or thrombin. Preliminary findings in our laboratory suggested that the expression of TFPI-2 is downregulated or lost during tumor progression in human gliomas. To investigate the role of TFPI-2 in the invasiveness of brain tumors, we stably transfected the human high-grade glioma cell line SNB19 and the human low-grade glioma cell line Hs683 with a vector capable of expressing a transcript complementary to the full-length TFPI-2 mRNA in either sense (0.7 kb) or antisense (1 kb) orientations. Parental cells and stably transfected cell lines were analysed for TFPI-2 protein by Western blotting and for TFPI-2 mRNA by Northern blotting. The levels of TFPI-2 protein and mRNA were higher in the sense clones (SNB19) and decreased in the antisense (Hs683) clones than in the corresponding parental and vector controls. In spheroid and matrigel invasion assays, the SNB19 parental cells were highly invasive, but the sense-transfected SNB-19 clones were much less invasive; the antisense-transfected Hs683 clones were more invasive than their parental and vector controls. After intracerebral injection in mice, the sense-transfected SNB19 clones were less able to form tumors than were their parental and vector controls, and the antisense-Hs683 clones hut not the parental or vector controls formed small tumors. This is the first study to demonstrate that down- or upregulation of TFPI-2 plays a significant role in the invasive behavior of human gliomas.

KW - Glioblastoma

KW - Invasion

KW - TFPI-2

UR - http://www.scopus.com/inward/record.url?scp=0035909515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035909515&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1204847

DO - 10.1038/sj.onc.1204847

M3 - Article

VL - 20

SP - 6938

EP - 6945

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 47

ER -